Scan beyond Kanadevia and this Tokyo trial by lining up other potential carbon and infrastructure beneficiaries using the hand picked 44 power grid technology and infrastructure stocks that could benefit as grids adapt to higher electrification and Waste to Energy demand.
To own Kanadevia, you need to buy into a fairly specific story. The business is trying to turn engineering depth in waste, machinery and decarbonization into steadier earnings, while dealing with thin net margins of 2.2% and profit pressure from past one off items and project issues. The Tokyo CO2 trial fits that effort, but it does not remove those near term execution questions.
Right now, the key short term swing factor is whether project work, including low carbon contracts, converts into clean, on budget revenue that supports the forecast earnings recovery. The biggest live risk is still further charges or cancellations on complex infrastructure jobs, which would keep returns and free cash flow tight and leave the dividend uncovered.
The high CO2 concentration Waste to Energy demonstration in Shinagawa is the announcement that most directly matters here. It sits inside Kanadevia’s Environment and Decarbonization activities, where the group is trying to build a pipeline that is less exposed to straightforward construction risk and more anchored in proprietary systems tied to carbon capture and circularity.
Set against the Oman green hydrogen collaboration, the Tokyo pilot gives you two different but related catalysts to watch. One is technology acceptance in Waste to Energy, including whether CO2 capture rates near 90% can be sustained at pilot scale. The other is whether this engineering track record helps Kanadevia win more decarbonization projects without repeating past cost overruns or compliance setbacks.
Kanadevia's narrative projects revenues of ¥752.2b and earnings of ¥29.5b by 2029. That profile lines up with analyst assumptions of 4.4% yearly revenue growth and an earnings increase of about ¥14.6b from earnings today of ¥14.9b.
Uncover why Kanadevia's fair value indicates a 22% potential upside to its current price, which could narrow quickly if Kanadevia's Tokyo trial reshapes sentiment.
Fair value estimates on Kanadevia from the Simply Wall St Community span roughly ¥1,300 to about ¥1,824, based on only 2 individual models, so opinions already stretch quite wide. When you also consider the Oman low carbon projects and the Tokyo CO2 trial, it becomes clear why future contract outcomes could push these views even further apart. Readers should treat this as a prompt to explore several alternative viewpoints rather than anchor on any single number.
Explore another Kanadevia fair value estimate, including one that suggests it could be worth just ¥1300!
Disagree with existing narratives? Extraordinary investment returns rarely come from following the herd, so trust your independent analysis and research.
Once you have a view on Kanadevia, it can help to line it up against other potential opportunities using the Simply Wall St Screener. That way you see where this stock fits alongside different return profiles, balance sheet quality levels and income characteristics.
Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team@simplywallst.com